Showing results (191-200 of 289) with videos related to
Sort By:
Pageof 29
Frontiers in Psychology|October 2, 2023
Self-reported traumatic brain injury in a sample of impulsive violent offenders: neuropsychiatric correlates and possible "dose effects"Vasudeva Murthy Challakere Ramaswamy, Tony Butler, Bianca Ton, et al.British Journal of Cancer|December 14, 2023
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancerDanka Sinikovic Zebic, Angelina Tjokrowidjaja, Katherine Elizabeth Francis, et al.British Journal of Cancer|January 25, 2017
Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)Kristina Lindemann, Emma Gibbs, Elisabeth Åvall-Lundqvist, et al.Diabetes, Obesity & Metabolism|April 4, 2020
Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD studyJacob Y Cao, Boris Waldman, Rachel O'Connell, et al.Gynecologic Oncology|October 5, 2014
Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trialChee Khoon Lee, Sarah Lord, Tami Grunewald, et al.European Journal of Cancer (Oxford, England : 1990)|July 7, 2019
Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapyChee Khoon Lee, Rebecca Asher, Michael Friedlander, et al.BMC Cancer|March 2, 2022
A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocolSina Vatandoust, David Wattchow, Luigi Sposato, et al.Journal of Medical Imaging and Radiation Oncology|October 28, 2014
Trans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) FrameworkGillian M Duchesne, Mel Grand, Tomas Kron, et al.World Journal of Gastroenterology|May 9, 2015
Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumabAflah Roohullah, Hui-Li Wong, Katrin M Sjoquist, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancerAndrew J Weickhardt, Tim J Price, Geoff Chong, et al.Pageof 29